Zacks Investment Research on MSN

Quest Diagnostics (DGX) down 4.2% since last earnings report: Can it rebound?

A month has gone by since the last earnings report for Quest Diagnostics (DGX). Shares have lost about 4.2% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...
Yahoo Finance

Quest Diagnostics Elects Timothy Wentworth, Former CEO of Walgreens Boots Alliance, Evernorth Health Services and Express Scripts, to Board of Directors

SECAUCUS, N.J., March 12, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced that its board of directors has ...

Guardant Health’s Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the Shieldâ„¢ by Guardant blood-based screening test is now widely accessible for physician order through ...
TMCnet

Quest Diagnostics Introduces AI Companion to Help Patients Understand and Act on Lab Test Results

SECAUCUS, N.J., March 2, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, ...
Fierce Biotech

Quest Diagnostics launches Google-powered AI chatbot to help patients understand lab results

By using a mobile app and patient portal called MyQuest, “adult users can prompt the tool to define test names and medical terminology from their results reports, as well as translate the meaning of ...

Quest Diagnostics Incorporated (DGX) Presents at Leerink Global Healthcare Conference 2026 Transcript

Leerink Global Healthcare Conference 2026 March 11, 2026 8:00 AM EDTCompany ParticipantsSam Samad - Executive VP ...
Reuters

Quest Diagnostics raises annual forecasts on strong diagnostic testing demand

July 22 (Reuters) - Laboratory operator Quest Diagnostics (DGX.N), opens new tab raised its 2025 profit and revenue forecasts on Tuesday, banking on robust demand for its diagnostic tests, sending the ...
Benzinga.com

Quest Diagnostics Reports Q3 Earnings, Shares Slide

What To Know: While Quest Diagnostics raised its revenue and adjusted earnings guidance for full-year 2025, the company lowered its GAAP earnings per share guidance to a range of $8.58 to $8.66 from a ...
Benzinga.com

Quest Diagnostics Analysts Increase Their Forecasts After Q3 Earnings

Quest Diagnostics (NASDAQ:DGX) posted better-than-expected earnings for the third quarter on Tuesday. While Quest Diagnostics raised its revenue and adjusted earnings guidance for full-year 2025, the ...
Nasdaq

Where Quest Diagnostics Stands With Analysts

In the last three months, 7 analysts have published ratings on Quest Diagnostics (NYSE:DGX), offering a diverse range of perspectives from bullish to bearish. In the table below, you'll find a summary ...
Seeking Alpha

Quest Diagnostics: The Better Half Of An Emerging Healthcare Duopoly

Quest Diagnostics is a dominant player in the growing medical testing industry, offering consistent earnings and dividend growth with lower volatility. DGX benefits from secular tailwinds like aging ...